Condition
Chronic Chagas Disease
Total Trials
3
Recruiting
0
Active
0
Completed
1
Success Rate
50.0%-37% vs avg
Key Insights
Highlights
Success Rate
50% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 80/100
Termination Rate
33.3%
1 terminated out of 3 trials
Success Rate
50.0%
-36.6% vs benchmark
Late-Stage Pipeline
33%
1 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
50% success
Data Visualizations
Phase Distribution
2Total
P 2 (1)
P 3 (1)
Trial Status
Withdrawn1
Completed1
Terminated1
Trial Success Rate
50.0%
Benchmark: 86.6%
Based on 1 completed trials
Clinical Trials (3)
Showing 3 of 3 trials
NCT07033325Completed
University-Based Chagas Testing in Salta Province, Argentina
NCT06339710Phase 3WithdrawnPrimary
Short Benznidazole Regimen for Chronic Phase Chagas Disease Patients
NCT04984616Phase 2TerminatedPrimary
Atorvastatin on Inflammation and Cardiac Function in Chronic Chagas Disease
Showing all 3 trials